Ohio Jury Faults Pharmacies for Spurring Opioid Epidemic

November 24, 2021 by Tom Ramstack
Ohio Jury Faults Pharmacies for Spurring Opioid Epidemic

CLEVELAND, Ohio — A landmark jury verdict Tuesday could make major pharmacy chains like CVS, Walgreens and Walmart liable for encouraging the opioid epidemic that kills thousands of Americans each year. 

The verdict in federal court in Ohio is the first to uphold a legal theory underpinning about 3,000 lawsuits nationwide.

Unlike other recent judgments in Oklahoma and California state courts, the U.S. District Court in Cleveland found that the pharmacies created a “public nuisance” by selling a dangerous drug despite its known risks of addiction, overdose and death.

If the decision survives on appeal, it would vastly increase the liability for opioid complications, according to attorneys who handled the case.

The pharmacies “engaged in intentional and/or illegal conduct [that] was a substantial factor in producing the public nuisance,” according to the verdict form. 

A separate court proceeding is scheduled for the spring to determine the penalty for the pharmacies. The plaintiffs are suggesting more than $1 billion for addiction treatment of residents in the two Ohio counties that sued.

“Today’s verdict represents a milestone victory for the Lake County and Trumbull County communities, and the entire country, in the fight against the opioid epidemic,” lawyers for the plaintiffs said in a joint statement.

Lake and Trumbull county officials blamed the pharmacies for making opioids available to consumers in amounts that far exceeded their medical needs. The pharmacies’ business practices “produced a permanent or long-lasting effect upon the public right,” their Aug. 19, 2021 court filing says. 

The trial was the first to hold pharmacies responsible for the opioid epidemic and the first that represented a victory for a local government. Other lawsuits have named opioid distributors and manufacturers as defendants.

The Oklahoma Supreme Court overturned a $465 million judgment this month against pharmaceutical company Johnson & Johnson. In California this month, a judge dismissed a lawsuit against drug manufacturers that make opioids.

All three of the pharmacies said they would appeal. They argued during the trial that they complied with all laws and Food and Drug Administration regulations.

If anyone other than the patients were to be blamed, it was the doctors, they said.

“Prescribers, they have the greatest control over the spigot,” said Brian Swanson, attorney for Walgreens, during closing arguments.

A Walgreens statement said “the trial court committed significant legal errors in allowing the case to go before a jury on a flawed legal theory that is inconsistent with Ohio law.”

A Walmart statement said the trial “was engineered to favor the plaintiffs’ attorneys and was riddled with remarkable legal and factual mistakes.”

CVS officials said they “look forward to the appeals court review of this case, including the misapplication of public nuisance law.”

Tom can be reached at [email protected].


A+
a-
  • CVS
  • pharmacies
  • Walgreens
  • Walmart
  • In The News

    Health

    Voting

    Prescription Drugs

    September 20, 2023
    by TWN Staff
    DHS Homeland Security Investigations Releases Strategy to Combat Illicit Opioids

    WASHINGTON — The Department of Homeland Security’s Homeland Security Investigations on Tuesday released the Strategy for Combating Illicit Opioids, an... Read More

    WASHINGTON — The Department of Homeland Security’s Homeland Security Investigations on Tuesday released the Strategy for Combating Illicit Opioids, an intelligence-driven approach to disrupting and dismantling transnational criminal organizations and keeping dangerous substances, like illicit fentanyl driving the overdose epidemic, off America’s streets.  The strategy leverages... Read More

    Biden's Medicare Price Negotiation Push Is Broadly Popular. He's Not Getting Much Credit

    WASHINGTON (AP) — President Joe Biden is trumpeting Medicare's new powers to negotiate directly with drugmakers on the cost of prescription medications — but... Read More

    WASHINGTON (AP) — President Joe Biden is trumpeting Medicare's new powers to negotiate directly with drugmakers on the cost of prescription medications — but a poll shows that any immediate political boost that Biden gets for enacting the overwhelmingly popular policy may be limited. Three-quarters of Americans, or 76%, favor... Read More

    September 11, 2023
    by Dan McCue
    CDC Awards $279M to 49 States, DC to Prevent Drug Overdoses

    ATLANTA — The Centers for Disease Control and Prevention awarded $279 million to 49 states, the District of Columbia and... Read More

    ATLANTA — The Centers for Disease Control and Prevention awarded $279 million to 49 states, the District of Columbia and 40 local health departments to help stem the tide of overdoses within their communities.  The agency announced the awards on International Overdose Awareness Day, a day... Read More

    Biden Targets Diabetes Drug Jardiance and Nine Others for Medicare Price Talks

    WASHINGTON (AP) — The Biden administration is targeting the blood thinner Eliquis, diabetes treatment Jardiance and eight other medications for... Read More

    WASHINGTON (AP) — The Biden administration is targeting the blood thinner Eliquis, diabetes treatment Jardiance and eight other medications for Medicare's first-ever drug price negotiations as it seeks to lower medical costs for Americans. The administration on Tuesday released a list of the 10 drugs for which prices... Read More

    July 26, 2023
    by Dan McCue
    House Dem Leaders Intro New Drug Price Legislation

    WASHINGTON — A trio of House Democrats introduced legislation Wednesday that would extend the savings garnered by the federal government... Read More

    WASHINGTON — A trio of House Democrats introduced legislation Wednesday that would extend the savings garnered by the federal government from negotiating prescription drug prices to all who are covered by private health plans. The bill, called the Lowering Drug Costs for American Families Act, was... Read More

    Second Alzheimer's Drug in Pipeline Can Slow Disease but With Safety Risk

    WASHINGTON (AP) — Another experimental Alzheimer’s drug can modestly slow patients’ inevitable worsening — by about four to seven months,... Read More

    WASHINGTON (AP) — Another experimental Alzheimer’s drug can modestly slow patients’ inevitable worsening — by about four to seven months, researchers reported Monday. Eli Lilly and Co. is seeking Food and Drug Administration approval of donanemab. If cleared, it would be only the second Alzheimer’s treatment... Read More

    News From The Well
    scroll top